Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ben Ma
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0009-0007-4228-5410
Observed ORCID:
0009-0007-4228-5410
OpenAlex ID:
A5009451845
Multiple bone brown tumor secondary to primary hyperparathyroidism: a case report and literature review
2019
·
Weibo Xu
, Yanqing Qu
, et al.
·
Gland Surgery
·
33
PDF
BRAF V600E /p-ERK/p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer
2024
·
Shi-Shuai Wen
, Yi-Jun Wu
, et al.
·
Thyroid
·
24
Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer
2024
·
Ben Ma
, Youzhou Sang
, et al.
·
Advanced Science
·
13
PDF
Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2023
·
Cenkai Shen
, Xiao Shi
, et al.
·
Clinical Cancer Research
·
11
Association of Lymph Nodes Positive Rate With the Risk of Recurrence in Patients With Stage T1 Papillary Thyroid Cancer
2024
·
Chao Qin
, Sijia Cai
, et al.
·
Journal of the Endocrine Society
·
6
Supplementary Methods 1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Data from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Figure S2 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S3 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
PDF
Figure S3 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Table S1 from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Data from Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System
2024
·
Cenkai Shen
, Xiao Shi
, et al.
Show more works
View as search
Works count:
18
Citation count:
87
H-index:
5
I10-index:
4
Year
Topic
Type